Home

Silvia Nozza

Profession:

Infectious disease specialist

Languages:

Biography

Dr. Silvia Nozza is an infectious diseases physician at the Department of Infectious Diseases of the IRCCS Ospedale San Raffaele Turro under the supervision of Professor Antonella Castagna, where she heads the Functional Department of Prevention and Vaccination.

After graduating from the University of Milan in Medicine and Surgery in 1998, she specialized in infectious diseases in 2004 at the Vita Salute San Raffaele University of Milan.

Clinically, Dr. Nozza is an expert in the field of HIV and Sars-Cov-2 infection, as well as in the field of vaccination; in addition, she has gained special experience in the prevention of HIV infection, as well as in the prevention and treatment of sexually transmitted infections.

As for the field of research, the doctor is the main researcher of INACTION (Italian Network of Acute HIV Infection), within which she coordinates the work of 20 Italian centers, as well as the main researcher of GEPPO (Geriatric Patients Living with HIV/AIDS), a promising multidimensional HIV study/AIDS.

She is the author and co-author of numerous scientific articles published in international journals and book chapters. She constantly participates in international congresses and conferences in the industry.

Do you need an appointment?

Request an appointment

Publications

Latest publications

Anti-Tat immunity defines CD4+ Tcell dynamics in people living with HIV on long-term cART

EBioMedicine. 2021 Mar 30:103306. doi: 10.1016/j.ebiom.2021.103306. Epub ahead of print. PMID: 33839064.

Tripiciano A, Picconi O, Moretti S, Sgadari C, Cafaro A, Francavilla V, Arancio A, Paniccia G, Campagna M, Pavone-Cossut MR, Sighinolfi L, Latini A, Mercurio VS, Pietro MD, Castelli F, Saracino A, Mussini C, Perri GD, Galli M, Nozza S, Ensoli F, Monini P, Ensoli B.

Residual viremia in HIV-infected patients who continue a 2-drug or switch to a 3-drug integrase strand transfer inhibitor-based regimen.

AIDS. 2021 Apr 6. doi: 10.1097/QAD.0000000000002908. Epub ahead of print. PMID: 33831909.

Gianotti N, Galli L, Poli A, Torre LD, Vinci C, Carini E, Galli A, Nozza S, Spagnuolo V, Muccini C, Lazzarin A, Castagna A.

Dolutegravir is not associated with weight gain in antiretroviral therapy experienced geriatric patients living with HIV.

AIDS. 2021 May 1;35(6):939-945. doi: 10.1097/QAD.0000000000002853. PMID: 33635844.

Guaraldi G, Calza S, Milic J, Calcagno A, Focà E, Rota M, Renzetti S, Celotti A, Siano M, Celesia BM, Piconi S, de Socio GV, Cattelan AM, Orofino G, Riva A, Nozza S, di Perri G

Icona Foundation Cohort. The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort

J Viral Hepat. 2021 Feb 18. doi: 10.1111/jvh.13488. Epub ahead of print. PMID: 33600068.

Bandera A, Lorenzini P, Taramasso L, Cozzi-Lepri A, Lapadula G, Mussini C, Saracino A, Ceccherini- Silberstein F, Puoti M, Quiros-Roldan E, Montagnani F, Antinori A, d'Arminio Monforte A, Gori A

Exercise ECG for coronary artery disease screening in people living with HIV.

AIDS. 2021 May 1;35(6):933-938. doi: 10.1097/QAD.0000000000002828. PMID: 33534202.

Muccini C, Galli L, Poli A, Godino C, Gianotti N, Nozza S, Giusti MC, Lazzarin A, Margonato A, Castagna A, Spagnuolo V.

ICONA Foundation Study Group. HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected Patients.

Open Forum Infect Dis. 2020 Nov 18;8(1):ofaa566. doi: 10.1093/ofid/ofaa566. PMID: 33447635; PMCID: PMC7781466

Malagnino V, Cerva C, Cingolani A, Ceccherini-Silberstein F, Vergori A, Cuomo G, Perno CF, Puoti M, d'Arminio Monforte A, Cozzi-Lepri A, Andreoni M, Sarmati L

Italian Society of Infectious and Tropical Diseases. Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT).

Clin Microbiol Infect. 2021 Mar;27(3):389-395. doi: 10.1016/j.cmi.2020.12.011. Epub 2021 Jan 18. PMID: 33359375; PMCID: PMC7833273

Mussini C, Falcone M, Nozza S, Sagnelli C, Parrella R, Meschiari M, Petrosillo N, Mastroianni C, Cascio A, Iaria C, Galli M, Chirianni A, Sagnelli E, Iacobello C, Di Perri G, Mazzotta F, Carosi G, Tinelli M, Grossi P, Armignacco O, Portelli V, Andreoni M, Tavio M

Allogeneic bone marrow transplantation in HIV people with hematological malignancies: Post-transplant cyclophosphamide to overcome the HLA-matching barrier

Transpl Infect Dis. 2020 Dec 22:e13551. doi:10.1111/tid.13551. Epub ahead of print. PMID: 33351984

Oltolini C, Piemontese S, Ripa M, Greco R, Nozza S, Corti C, Peccatori J, Scarpellini P, Ciceri F, Castagna A

COVID-BioB study group. Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19.

Sci Rep. 2020 Dec 4;10(1):21291. doi: 10.1038/s41598-020-78039-1. PMID: 33277573; PMCID: PMC7718220

Spagnuolo V, Guffanti M, Galli L, Poli A, Querini PR, Ripa M, Clementi M, Scarpellini P, Lazzarin A, Tresoldi M, Dagna L, Zangrillo A, Ciceri F, Castagna A

COVID-BioB study group. Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors.

Clin Microbiol Infect. 2021 Mar;27(3):451-457. doi:10.1016/j.cmi.2020.10.021. Epub 2020 Oct 24. PMID: 33223114; PMCID: PMC7584496.

Ripa M, Galli L, Poli A, Oltolini C, Spagnuolo V, Mastrangelo A, Muccini C, Monti G, De Luca G, Landoni G, Dagna L, Clementi M, Rovere Querini P, Ciceri F, Tresoldi M, Lazzarin A, Zangrillo A, Scarpellini P, Castagna A

Do you need an appointment?

Request an appointment